VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr |
What is the latest Contingent Liabilities ratio of VENKYS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹16 Cr |
How is Contingent Liabilities of VENKYS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | 8.77 | |
| Mar2024 | ₹17 Cr | -0.37 | |
| Mar2023 | ₹17 Cr | 4.53 | |
| Mar2022 | ₹16 Cr | 1.97 | |
| Mar2021 | ₹16 Cr | - | |
Compare Contingent Liabilities of peers of VENKYS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENKYS (INDIA) | ₹1,972.9 Cr | -2.7% | -3.8% | -17% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,465.8 Cr | -0.3% | 3.1% | -6.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,312.7 Cr | -3.8% | 4.4% | -8.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹972.8 Cr | 1.8% | 0% | -35.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹389.9 Cr | -2.4% | -5.7% | -6.2% | Stock Analytics | |
| INDO US BIOTECH | ₹292.1 Cr | 10.3% | 29.9% | -31% | Stock Analytics | |
VENKYS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENKYS (INDIA) | -2.7% |
-3.8% |
-17% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses